2023
Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia
Ramakrishnan A, Datta I, Panja S, Patel H, Liu Y, Craige M, Chu C, Jean-Marie G, Oladoja A, Kim I, Mitrofanova A. Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia. Frontiers In Oncology 2023, 13: 1222168. PMID: 37746266, PMCID: PMC10512286, DOI: 10.3389/fonc.2023.1222168.Peer-Reviewed Original ResearchAcute myeloid leukemiaProstate cancerYears of ageAML progressionCancer progressionMyeloid leukemiaStratified survival analysisBiological agingHigh Gleason scoreCox proportional hazardsMarker of progressionProstate cancer progressionPersonalized therapeutic managementMultiple cancer typesAML incidenceOverall survivalPrognostic factorsGleason scoreTherapeutic managementPatient cohortRisk scorePatientsCancer aggressivenessChronological agingProportional hazards
2013
Korean Prostate Cancer Patients Have Worse Disease Characteristics than their American Counterparts
Kang D, Chung J, Ha H, Min K, Yoon J, Kim W, Seo W, Kang P, Jung S, Kim I. Korean Prostate Cancer Patients Have Worse Disease Characteristics than their American Counterparts. Asian Pacific Journal Of Cancer Prevention 2013, 14: 6913-6917. PMID: 24377625, DOI: 10.7314/apjcp.2013.14.11.6913.Peer-Reviewed Original ResearchConceptsBody mass indexHigh Gleason scoreGleason scoreProstate cancerT stageRadical prostatectomyPreoperative prostate-specific antigen levelProstate cancer treatment strategiesProstate-specific antigen levelMean body mass indexKorean prostate cancer patientsMean preoperative PSAWorse disease characteristicsAdvanced prostate cancerPathological T stageHigher T stageProstate cancer patientsHigher PSA valuesMalignant prostate cancerCancer treatment strategiesPreoperative PSAMass indexProstate sizePSA testPSA values